NeuBase Therapeutics Inc (NBSE)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
NeuBase Therapeutics Cash from Operations (Quarterly): -2.003M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.003M |
| June 30, 2023 | -3.644M |
| March 31, 2023 | -3.448M |
| December 31, 2022 | -5.688M |
| September 30, 2022 | -6.638M |
| June 30, 2022 | -8.913M |
| March 31, 2022 | -8.192M |
| December 31, 2021 | -5.268M |
| September 30, 2021 | -5.442M |
| June 30, 2021 | -6.13M |
| March 31, 2021 | -3.521M |
| December 31, 2020 | -3.781M |
| September 30, 2020 | -3.568M |
| June 30, 2020 | -2.885M |
| March 31, 2020 | -1.816M |
| December 31, 2019 | -2.442M |
| September 30, 2019 | -0.5969M |
| June 30, 2019 | -0.7046M |
| March 31, 2019 | -0.9771M |
| December 31, 2018 | -0.5668M |
| September 30, 2018 | -0.5966M |
| June 30, 2018 | -1.182M |
| March 31, 2018 | -3.519M |
| December 31, 2017 | -4.196M |
| September 30, 2017 | -5.275M |
| Date | Value |
|---|---|
| June 30, 2017 | -4.118M |
| March 31, 2017 | -3.968M |
| December 31, 2016 | -5.930M |
| September 30, 2016 | -5.032M |
| June 30, 2016 | -4.184M |
| March 31, 2016 | -3.443M |
| December 31, 2015 | -3.326M |
| September 30, 2015 | -2.209M |
| June 30, 2015 | -1.678M |
| March 31, 2015 | -4.068M |
| December 31, 2014 | -2.738M |
| September 30, 2014 | -1.578M |
| June 30, 2014 | -1.947M |
| March 31, 2014 | -0.5429M |
| December 31, 2013 | -1.293M |
| September 30, 2013 | -0.9244M |
| June 30, 2013 | -0.7279M |
| March 31, 2013 | -0.3762M |
| December 31, 2012 | -0.6611M |
| September 30, 2012 | -0.5198M |
| June 30, 2012 | -0.4247M |
| March 31, 2012 | -0.5852M |
| December 31, 2011 | -0.2242M |
| September 30, 2011 | -0.4088M |
| June 30, 2011 | -0.2296M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.913M
Minimum
Jun 2022
-0.5969M
Maximum
Sep 2019
-4.149M
Average
-3.606M
Median
Cash from Operations (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | -2.309M |
| Stoke Therapeutics Inc | -24.57M |
| ABVC BioPharma Inc | -0.4795M |
| MAIA Biotechnology Inc | -3.992M |
| Aprea Therapeutics Inc | -3.740M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.1745M |
| Free Cash Flow | -14.85M |
| Free Cash Flow Per Share (Quarterly) | -0.7262 |
| Free Cash Flow Yield | -2.02K% |